Related Experiment Videos
[Angiogenesis in human cerebral ischemia].
A Rosell-Novel1, J Montaner, J Alvarez-Sabín
1Laboratorio de Investigación Neurovascular, Unidad Neurovascular, Servicio de Neurología, Hospital Universitari Vall d'Hebron, Barcelona, Spain. arosell@vhebron.net
Revista De Neurologia
|June 18, 2004
Summary
Angiogenesis, the formation of new blood vessels, is activated after stroke. Future therapies may target this process to aid stroke recovery.
Area of Science:
- Neuroscience
- Vascular Biology
- Regenerative Medicine
Context:
- Angiogenesis, the growth of new blood vessels, involves complex molecular regulation with both beneficial and detrimental roles in human diseases.
- In cerebrovascular diseases, particularly ischemic stroke, angiogenesis is activated, but its precise role and therapeutic potential remain largely unexplored.
- Key molecular players include vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), matrix metalloproteinases (MMPs), and their inhibitors like angiostatin and endostatin.
Purpose:
- To review current understanding of angiogenesis following stroke.
- To explore the potential benefits of future therapeutic strategies targeting angiogenic processes in stroke patients.
Summary:
- Following ischemic stroke, the body activates angiogenesis, altering the brain's capillary network.
- Understanding the temporal dynamics and specific molecular profiles of angiogenesis in acute and chronic stroke phases is crucial.
- Modulating angiogenesis holds promise as a component of future combination therapies for stroke.
Impact:
- This review highlights the potential of targeting angiogenesis for stroke treatment and recovery.
- Further research into the temporal aspects and molecular mechanisms of post-stroke angiogenesis is warranted.
- Angiogenesis modulation could represent a novel therapeutic avenue to improve outcomes for stroke survivors.